Clinical Trial: A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus

U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07630714) titled 'A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus' on June 02.

Brief Summary: The purpose of this study is to characterize the pharmacokinetics (PK), pharmacodynamics (PD), and safety of subcutaneous (SC) anifrolumab in pediatric participants with moderate to severe systemic lupus erythematosus (SLE) while on background standard of care (SoC) therapy.

Study Start Date: July 28

Study Type: INTERVENTIONAL

Condition: Systemic Lupus Erythematosus

Intervention: COMBINATION_PRODUCT: Anifrolumab + APFS

An...